{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T01:28:28Z","timestamp":1792200508528,"version":"4.4.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100007737","name":"St. Jude Children's Research Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007737","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/s12889-025-23928-1","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T06:10:53Z","timestamp":1755583853000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Analysis of factors driving HPV vaccination coverage and associated cost savings in the united States"],"prefix":"10.1186","volume":"25","author":[{"given":"Shanshan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjana","family":"Muthukrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabiha","family":"Quddus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan H.","family":"Manning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather M.","family":"Brandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,19]]},"reference":[{"key":"23928_CR1","unstructured":"Centers for Disease Control and Prevention. HPV Infection 2023 [updated February 10, 2023. Available from: https:\/\/www.cdc.gov\/hpv\/parents\/about-hpv.html"},{"key":"23928_CR2","unstructured":"Centers for Disease Control and Prevention. HPV-Associated Cancer Statistics 2022 [updated October 3, 2022. Available from: https:\/\/www.cdc.gov\/cancer\/hpv\/statistics\/index.htm"},{"key":"23928_CR3","unstructured":"Centers for Disease Control and Prevention. Genital HPV Infection\u2013 Basic Fact Sheet 2022 [Available from: https:\/\/www.cdc.gov\/std\/hpv\/stdfact-hpv.htm"},{"issue":"4","key":"23928_CR4","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1097\/OLQ.0000000000001379","volume":"48","author":"HW Chesson","year":"2021","unstructured":"Chesson HW, Laprise J-F, Brisson M, Martin D, Ekwueme DU, Markowitz LE. The estimated lifetime medical cost of diseases attributable to human papillomavirus infections acquired in 2018. Sex Transm Dis. 2021;48(4):278\u201384.","journal-title":"Sex Transm Dis"},{"key":"23928_CR5","unstructured":"National Cancer Institute. Cancer Trends Progress Report: Financial Burden of Cancer Care. 2022."},{"issue":"14","key":"23928_CR6","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1016\/j.vaccine.2023.02.049","volume":"41","author":"PA Clay","year":"2023","unstructured":"Clay PA, Thompson TD, Markowitz LE, Ekwueme DU, Saraiya M, Chesson HW. Updated estimate of the annual direct medical cost of screening and treatment for human papillomavirus associated disease in the United States. Vaccine. 2023;41(14):2376\u201381.","journal-title":"Vaccine"},{"key":"23928_CR7","unstructured":"Centers for Disease Control and Prevention. HPV Vaccination is Safe and Effective 2021 [updated July 23, 2021. Available from: https:\/\/www.cdc.gov\/hpv\/parents\/vaccinesafety.html"},{"issue":"1","key":"23928_CR8","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1186\/s12889-019-6566-y","volume":"19","author":"M Franco","year":"2019","unstructured":"Franco M, Mazzucca S, Padek M, Brownson RC. Going beyond the individual: how state-level characteristics relate to HPV vaccine rates in the United States. BMC Public Health. 2019;19(1):246.","journal-title":"BMC Public Health"},{"issue":"32","key":"23928_CR9","doi-asserted-by":"publisher","first-page":"698","DOI":"10.15585\/mmwr.mm6832a3","volume":"68","author":"E Meites","year":"2019","unstructured":"Meites E, Szilagyi PG, Chesson HW, Unger ER, Romero JR, Markowitz LE. Human papillomavirus vaccination for adults: updated recommendations of the advisory committee on immunization practices. MMWR Morbidity Mortal Wkly Rep. 2019;68(32):698\u2013702.","journal-title":"MMWR Morbidity Mortal Wkly Rep"},{"issue":"35","key":"23928_CR10","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.15585\/mmwr.mm7035a1","volume":"70","author":"C Pingali","year":"2021","unstructured":"Pingali C, Yankey D, Elam-Evans LD, Markowitz LE, Williams CL, Fredua B, et al. National, regional, state, and selected local area vaccination coverage among adolescents aged 13\u201317 Years \u2014 United states, 2020. MMWR Morbidity Mortal Wkly Rep. 2021;70(35):1183\u201390.","journal-title":"MMWR Morbidity Mortal Wkly Rep"},{"key":"23928_CR11","unstructured":"Centers for Disease Control and Prevention. HPV Vaccination Recommendations 2021 [Available from: https:\/\/www.cdc.gov\/vaccines\/vpd\/hpv\/hcp\/recommendations.html"},{"issue":"8","key":"23928_CR12","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1016\/j.vaccine.2019.12.030","volume":"38","author":"S Inguva","year":"2020","unstructured":"Inguva S, Barnard M, Ward LM, Yang Y, Pittman E, Banahan BF, et al. Factors influencing human papillomavirus (HPV) vaccination series completion in Mississippi Medicaid. Vaccine. 2020;38(8):2051\u20137.","journal-title":"Vaccine"},{"issue":"1","key":"23928_CR13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12889-017-4567-2","volume":"18","author":"KA Henry","year":"2017","unstructured":"Henry KA, Swiecki-Sikora AL, Stroup AM, Warner EL, Kepka D. Area-based socioeconomic factors and human papillomavirus (HPV) vaccination among teen boys in the United States. BMC Public Health. 2017;18(1):19.","journal-title":"BMC Public Health"},{"issue":"4","key":"23928_CR14","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/jrh.12353","volume":"35","author":"AL Swiecki-Sikora","year":"2019","unstructured":"Swiecki-Sikora AL, Henry KA, Kepka D. HPV vaccination coverage among US teens across the rural-urban continuum. J Rural Health. 2019;35(4):506\u201317.","journal-title":"J Rural Health"},{"key":"23928_CR15","doi-asserted-by":"publisher","unstructured":"Chen S-T, Huybrechts KF, Bateman BT, Hern\u00e1ndez-D\u00edaz S. Trends in human papillomavirus vaccination in commercially insured children in the United States. Pediatrics. 2020;146(4):e20193557. https:\/\/doi.org\/10.1542\/peds.2019-3557.","DOI":"10.1542\/peds.2019-3557"},{"issue":"6","key":"23928_CR16","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1177\/1059840511415861","volume":"27","author":"JA Bartlett","year":"2011","unstructured":"Bartlett JA, Peterson JA. The uptake of human papillomavirus (HPV) vaccine among adolescent females in the United States: a review of the literature. J Sch Nurs. 2011;27(6):434\u201346.","journal-title":"J Sch Nurs"},{"issue":"5","key":"23928_CR17","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.amepre.2021.04.031","volume":"61","author":"LN Mansfield","year":"2021","unstructured":"Mansfield LN, Silva SG, Merwin EI, Chung RJ, Gonzalez-Guarda RM. Factors associated with human papillomavirus vaccine series completion among adolescents. Am J Prev Med. 2021;61(5):701\u20138.","journal-title":"Am J Prev Med"},{"issue":"3","key":"23928_CR18","doi-asserted-by":"publisher","first-page":"866","DOI":"10.4103\/jfmpc.jfmpc_107_19","volume":"8","author":"S Sriram","year":"2019","unstructured":"Sriram S, Ranganathan R. Why human papilloma virus vaccination coverage is low among adolescents in the US? A study of barriers for vaccination uptake. J Family Med Prim Care. 2019;8(3):866\u201370.","journal-title":"J Family Med Prim Care"},{"key":"23928_CR19","doi-asserted-by":"publisher","unstructured":"Daniel CL, Lawson F, Vickers M, Green C, Wright A, Coyne-Beasley T, et al. Enrolling a rural community pharmacy as a vaccines for children provider to increase HPV vaccination: a feasibility study. BMC Public Health. 2021;21(1):1266. https:\/\/doi.org\/10.1186\/s12889-021-11304-8.","DOI":"10.1186\/s12889-021-11304-8"},{"issue":"1","key":"23928_CR20","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2021.2016304","volume":"18","author":"SR Newcomer","year":"2022","unstructured":"Newcomer SR, Freeman RE, Albers AN, Murgel S, Thaker J, Rechlin A, et al. Missed opportunities for human papillomavirus vaccine series initiation in a large, rural U.S. state. Hum Vaccin Immunother. 2022;18(1): 2016304.","journal-title":"Hum Vaccin Immunother"},{"key":"23928_CR21","doi-asserted-by":"publisher","unstructured":"Hawkins SS, Horvath K, Cohen J, Pace LE, Baum CF. Associations between insurance-related Affordable Care Act policy changes with HPV vaccine completion. BMC Public Health. 2021;21(1):304. https:\/\/doi.org\/10.1186\/s12889-021-10328-4.","DOI":"10.1186\/s12889-021-10328-4"},{"issue":"4","key":"23928_CR22","doi-asserted-by":"publisher","first-page":"493","DOI":"10.2105\/AJPH.2017.304263","volume":"108","author":"MC Roberts","year":"2018","unstructured":"Roberts MC, Murphy T, Moss JL, Wheldon CW, Psek W. A qualitative comparative analysis of combined state health policies related to human papillomavirus vaccine uptake in the United States. Am J Public Health. 2018;108(4):493\u20139.","journal-title":"Am J Public Health"},{"key":"23928_CR23","doi-asserted-by":"publisher","unstructured":"Ag\u00e9nor M, Unger ES, McConnell MA, Brown C, Rosenthal MB, Haneuse S, et al. Affordable care act state medicaid expansion and human papillomavirus vaccination among adolescent and young adult US women: a national study. Health Serv Res. 2023;58(4):792\u20139. https:\/\/doi.org\/10.1111\/1475-6773.14133.","DOI":"10.1111\/1475-6773.14133"},{"issue":"1","key":"23928_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-022-12573-7","volume":"22","author":"B Anuforo","year":"2022","unstructured":"Anuforo B, McGee-Avila JK, Toler L, Xu B, Kohler RE, Manne S, et al. Disparities in HPV vaccine knowledge and adolescent HPV vaccine uptake by parental nativity among diverse multiethnic parents in new Jersey. BMC Public Health. 2022;22(1): 195.","journal-title":"BMC Public Health"},{"issue":"7","key":"23928_CR25","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1093\/jpepsy\/jsp108","volume":"35","author":"HL Gamble","year":"2010","unstructured":"Gamble HL, Klosky JL, Parra GR, Randolph ME. Factors influencing familial decision-making regarding human papillomavirus vaccination. J Pediatr Psychol. 2010;35(7):704\u201315.","journal-title":"J Pediatr Psychol"},{"key":"23928_CR26","unstructured":"TeenVaxView [Internet]. 2021. Available from: https:\/\/www.cdc.gov\/vaccines\/imz-managers\/coverage\/teenvaxview\/index.html"},{"key":"23928_CR27","unstructured":"National Center for Immunization and Respiratory Diseases. The 2021 National immunization Survey - Teen. U.S. Department of health and human services (DHHS). editor. Atlanta, GA: Centers for Disease Control and Prevention; 2022. https:\/\/odphp.health.gov\/healthypeople\/objectives-and-data\/data-sources-and-methods\/data-sources\/national-immunization-survey-teen-nis-teen."},{"key":"23928_CR28","unstructured":"American Community Survey [Internet]. 2021. Available from: https:\/\/www.census.gov\/programs-surveys\/acs\/data.html"},{"key":"23928_CR29","unstructured":"Education Demographics and Geographic Estimates. (2016\u20132020) [Internet]. 2020. Available from: https:\/\/nces.ed.gov\/programs\/edge\/tableviewer\/acsProfile\/2020"},{"key":"23928_CR30","unstructured":"U.S. Census Bureau. Urban and Rural: Demographic and Housing Characteristics. 2020."},{"key":"23928_CR31","unstructured":"Medicaid.gov, Medicaid. Children\u2019s Health Insurance Program, & Basic Health Program Eligibility Levels 2022 [Available from: https:\/\/www.medicaid.gov\/medicaid\/national-medicaid-chip-program-information\/medicaid-childrens-health-insurance-program-basic-health-program-eligibility-levels\/index.html"},{"key":"23928_CR32","unstructured":"State Vaccine Requirements for Children [Internet]. 2021. Available from: https:\/\/www.kff.org\/other\/state-indicator\/state-vaccine-requirements-for-children\/?currentTimeframe=0&sortModel=%7B%22colId%22:%22Location%22,%22sort%22:%22asc%22%7D"},{"key":"23928_CR33","unstructured":"States With Religious and Philosophical Exemptions From School Immunization Requirements [Internet]. 2021. Available from: https:\/\/www.ncsl.org\/health\/states-with-religious-and-philosophical-exemptions-from-school-immunization-requirements"},{"key":"23928_CR34","unstructured":"State US. and County Distributions of General Pediatricians and Subspecialists [Internet]. 2021. Available from: https:\/\/www.abp.org\/content\/data-and-workforce"},{"key":"23928_CR35","doi-asserted-by":"publisher","unstructured":"Ryan G, Gilbert PA, Ashida S, Charlton ME, Scherer A, Askelson NM. Challenges to adolescent HPV vaccination and implementation of evidence-based interventions to promote vaccine uptake during the COVID-19 pandemic: HPV is probably not at the top of our list. Prev Chronic Dis. 2022;19:210378. https:\/\/doi.org\/10.5888\/pcd19.210378.","DOI":"10.5888\/pcd19.210378"},{"issue":"20","key":"23928_CR36","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1016\/j.vaccine.2021.04.003","volume":"39","author":"V Daniels","year":"2021","unstructured":"Daniels V, Saxena K, Roberts C, Kothari S, Corman S, Yao L, et al. Impact of reduced human papillomavirus vaccination coverage rates due to COVID-19 in the United States: a model based analysis. Vaccine. 2021;39(20):2731\u20135.","journal-title":"Vaccine"},{"issue":"19","key":"23928_CR37","doi-asserted-by":"publisher","first-page":"529","DOI":"10.15585\/mmwr.mm7219e2","volume":"72","author":"HM Scobie","year":"2023","unstructured":"Scobie HM, Panaggio M, Binder AM, Gallagher ME, Duck WM, Graff P, et al. Correlations and timeliness of COVID-19 surveillance data sources and indicators \u2015 united states, October 1, 2020\u2013March 22, 2023. MMWR Morbidity Mortal Wkly Rep. 2023;72(19):529\u201335.","journal-title":"MMWR Morbidity Mortal Wkly Rep"},{"key":"23928_CR38","unstructured":"COVID-19 Mortality by State [Internet]. 2021. Available from: https:\/\/www.cdc.gov\/nchs\/pressroom\/sosmap\/covid19_mortality_final\/COVID19.htm"},{"key":"23928_CR39","unstructured":"Kaiser Family Foundation. Status of State Medicaid Expansion Decisions 2021 [Available from: https:\/\/www.kff.org\/medicaid\/issue-brief\/status-of-state-medicaid-expansion-decisions-interactive-map\/"},{"key":"23928_CR40","unstructured":"National Cancer Institute. HPV and Cancer 2023 [Available from: https:\/\/www.cancer.gov\/about-cancer\/causes-prevention\/risk\/infectious-agents\/hpv-and-cancer"},{"key":"23928_CR41","unstructured":"CDC WONDER [Internet]. 2021. Available from: https:\/\/wonder.cdc.gov\/"},{"issue":"2","key":"23928_CR42","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.ygyno.2017.12.019","volume":"148","author":"S Fu","year":"2018","unstructured":"Fu S, Lairson DR, Chan W, Wu C-F, Ramondetta L. Mean medical costs associated with vaginal and vulvar cancers for commercially insured patients in the United States and Texas. Gynecol Oncol. 2018;148(2):342\u20138.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"23928_CR43","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ygyno.2017.02.011","volume":"145","author":"DR Lairson","year":"2017","unstructured":"Lairson DR, Fu S, Chan W, Xu L, Shelal Z, Ramondetta L. Mean direct medical care costs associated with cervical cancer for commercially insured patients in Texas. Gynecol Oncol. 2017;145(1):108\u201313.","journal-title":"Gynecol Oncol"},{"issue":"4","key":"23928_CR44","first-page":"294.e17","volume":"37","author":"DR Lairson","year":"2019","unstructured":"Lairson DR, Wu C-F, Chan W, Fu S, Hoffman KE, Pettaway CA. Mean treatment cost of incident cases of penile cancer for privately insured patients in the United States. Urol Oncol Semin Orig Investig. 2019;37(4):294.e17-e25.","journal-title":"Urol Oncol Semin Orig Investig"},{"issue":"11","key":"23928_CR45","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.18553\/jmcp.2018.24.11.1156","volume":"24","author":"C-F Wu","year":"2018","unstructured":"Wu C-F, Xu L, Fu S, Peng H-L, Messick CA, Lairson DR. Health care costs of anal Cancer in a commercially insured population in the united States. J Managed Care Specialty Pharm. 2018;24(11):1156\u201364.","journal-title":"J Managed Care Specialty Pharm"},{"issue":"2","key":"23928_CR46","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1097\/LGT.0000000000000472","volume":"23","author":"S Fu","year":"2019","unstructured":"Fu S, Fokom Domgue J, Chan W, Zhao B, Ramondetta LM, Lairson DR. Cervical, vaginal, and vulvar Cancer costs incurred by the medicaid program in publicly insured patients in Texas. J Lower Genit Tract Dis. 2019;23(2):102\u20139.","journal-title":"J Lower Genit Tract Dis"},{"issue":"2","key":"23928_CR47","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1097\/COC.0000000000000238","volume":"41","author":"AA Deshmukh","year":"2018","unstructured":"Deshmukh AA, Zhao H, Franzini L, Lairson DR, Chiao EY, Das P, et al. Total lifetime and cancer-related costs for elderly patients diagnosed with anal cancer in the United States. Am J Clin Oncol. 2018;41(2):121\u20137.","journal-title":"Am J Clin Oncol"},{"issue":"3","key":"23928_CR48","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.ijrobp.2015.11.006","volume":"94","author":"DJ Sher","year":"2016","unstructured":"Sher DJ, Fidler MJ, Tishler RB, Stenson K, al-Khudari S. Cost-Effectiveness analysis of chemoradiation therapy versus transoral robotic surgery for human Papillomavirus\u2013Associated, clinical N2 oropharyngeal Cancer. Int J Radiation Oncology*Biology*Physics. 2016;94(3):512\u201322.","journal-title":"Int J Radiation Oncology*Biology*Physics"},{"key":"23928_CR49","unstructured":"Centers for Disease Control and Prevention. How Many Cancers Are Linked with HPV Each Year? 2022 [Available from: https:\/\/www.cdc.gov\/cancer\/hpv\/statistics\/cases.htm"},{"key":"23928_CR50","unstructured":"Centers for Disease Control and Prevention. Cancers Caused by HPV Are Preventable 2021 [Available from: https:\/\/www.cdc.gov\/hpv\/hcp\/protecting-patients.html"},{"issue":"34","key":"23928_CR51","doi-asserted-by":"publisher","first-page":"912","DOI":"10.15585\/mmwr.mm7234a3","volume":"72","author":"C Pingali","year":"2023","unstructured":"Pingali C, Yankey D, Elam-Evans LD, Markowitz LE, Valier MR, Fredua B, et al. Vaccination coverage among adolescents aged 13\u201317 years - National immunization Survey-Teen, united states, 2022. MMWR Morb Mortal Wkly Rep. 2023;72(34):912\u20139.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"23928_CR52","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1080\/14760584.2023.2217257","volume":"22","author":"AL Eiden","year":"2023","unstructured":"Eiden AL, DiFranzo A, Bhatti A, Echo Wang H, Bencina G, Yao L, et al. Changes in vaccine administration trends across the life-course during the COVID-19 pandemic in the united states: a claims database study. Expert Rev Vaccines. 2023;22(1):481\u201394.","journal-title":"Expert Rev Vaccines"},{"issue":"5","key":"23928_CR53","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.vaccine.2021.12.064","volume":"40","author":"SA Kujawski","year":"2022","unstructured":"Kujawski SA, Yao L, Wang HE, Carias C, Chen YT. Impact of the COVID-19 pandemic on pediatric and adolescent vaccinations and well child visits in the United States: a database analysis. Vaccine. 2022;40(5):706\u201313.","journal-title":"Vaccine"},{"issue":"35","key":"23928_CR54","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.15585\/mmwr.mm7135a1","volume":"71","author":"C Pingali","year":"2022","unstructured":"Pingali C, Yankey D, Elam-Evans LD, Markowitz LE, Valier MR, Fredua B, et al. National vaccination coverage among adolescents aged 13\u201317 years - national immunization survey-teen, United States, 2021. MMWR Morb Mortal Wkly Rep. 2022;71(35):1101\u20138.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"12","key":"23928_CR55","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1080\/03007995.2021.1981842","volume":"37","author":"K Saxena","year":"2021","unstructured":"Saxena K, Marden JR, Carias C, Bhatti A, Patterson-Lomba O, Gomez-Lievano A, et al. Impact of the COVID-19 pandemic on adolescent vaccinations: projected time to reverse deficits in routine adolescent vaccination in the United States. Curr Med Res Opin. 2021;37(12):2077\u201387.","journal-title":"Curr Med Res Opin"},{"key":"23928_CR56","doi-asserted-by":"publisher","unstructured":"Adjei Boakye E, Nair M, Abouelella DK, Joseph CLM, Gerend MA, Subramaniam DS, et al. Trends in reasons for human papillomavirus vaccine hesitancy: 2010\u20132020. Pediatrics. 2023;151(6):e2022060410. https:\/\/doi.org\/10.1542\/peds.2022-060410.","DOI":"10.1542\/peds.2022-060410"},{"key":"23928_CR57","doi-asserted-by":"publisher","unstructured":"Shete S, Yu RK, Chido-Amajuoyi OG, Fokom Domgue J. Beliefs about HPV vaccine\u2019s success at cervical Cancer prevention among adult US women. JNCI Cancer Spectr. 2019;3(4):pkz064. https:\/\/doi.org\/10.1093\/jncics\/pkz064.","DOI":"10.1093\/jncics\/pkz064"},{"issue":"2","key":"23928_CR58","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1037\/sah0000230","volume":"6","author":"S Foster","year":"2021","unstructured":"Foster S, Carvallo M, Lee J, Fisher R, Traxler H. An implication of impurity: the impact of feminine honor on human papillomavirus (HPV) screenings and the decision to authorize daughter\u2019s HPV vaccinations. Stigma Health. 2021;6(2):216\u201327.","journal-title":"Stigma Health"},{"issue":"14","key":"23928_CR59","doi-asserted-by":"publisher","first-page":"5281","DOI":"10.1002\/cam4.3192","volume":"9","author":"J Fokom Domgue","year":"2020","unstructured":"Fokom Domgue J, Cunningham SA, Yu RK, Shete S. Reasons for not receiving the HPV vaccine among eligible adults: lack of knowledge and of provider recommendations contribute more than safety and insurance concerns. Cancer Med. 2020;9(14):5281\u201390.","journal-title":"Cancer Med"},{"key":"23928_CR60","unstructured":"Immunize.org. State Meningococcal ACWY (MenACWY) Vaccine Requirements for Secondary School 2023 [Available from: https:\/\/www.immunize.org\/laws\/menin_sec.asp"},{"issue":"7\u20138","key":"23928_CR61","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1080\/21645515.2019.1602433","volume":"15","author":"WA Calo","year":"2019","unstructured":"Calo WA, Shah PD, Gilkey MB, Vanderpool RC, Barden S, Doucette WR, et al. Implementing pharmacy-located HPV vaccination: findings from pilot projects in five U.S. states. Hum Vaccin Immunother. 2019;15(7\u20138):1831\u20138.","journal-title":"Hum Vaccin Immunother"},{"issue":"3","key":"23928_CR62","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.sapharm.2019.05.022","volume":"16","author":"BS Teeter","year":"2020","unstructured":"Teeter BS, Mosley C, Thomas JL, Martin B, Jones D, Romero JR, et al. Improving HPV vaccination using implementation strategies in community pharmacies: pilot study protocol. Res Social Adm Pharm. 2020;16(3):336\u201341.","journal-title":"Res Social Adm Pharm"},{"issue":"2","key":"23928_CR63","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/jphd.12566","volume":"83","author":"N Askelson","year":"2023","unstructured":"Askelson N, Ryan G, McKernan S, Scherer A, Daly E, Avdic L. Engaging new partners in human papillomavirus (HPV) vaccine promotion: considerations for training private practice dental professionals in HPV vaccine promotion. J Public Health Dent. 2023;83(2):185\u201392.","journal-title":"J Public Health Dent"},{"key":"23928_CR64","unstructured":"World Health Organisation. Cervical Cancer Elimination Initiative [Available from: https:\/\/www.who.int\/initiatives\/cervical-cancer-elimination-initiative"},{"issue":"2","key":"23928_CR65","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2023.2251815","volume":"19","author":"MB Shin","year":"2023","unstructured":"Shin MB, Sloan K, Baezconde-Garbanati L, Dang E, Garcia S, Palinkas LA, et al. Multilevel perspectives on school-based opportunities to improve HPV vaccination among medically underserved adolescents: beyond school entry mandates. Hum Vaccin Immunother. 2023;19(2): 2251815.","journal-title":"Hum Vaccin Immunother"},{"key":"23928_CR66","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1099552","volume":"11","author":"K Sloan","year":"2023","unstructured":"Sloan K, Shin M, Palinkas LA, Hudson SV, Crabtree BF, Cantor JC, et al. Exploring HPV vaccination policy and payer strategies for opportunities to improve uptake in safety-net settings. Front Public Health. 2023;11: 1099552.","journal-title":"Front Public Health"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-23928-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-025-23928-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-23928-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T16:49:31Z","timestamp":1757436571000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-025-23928-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,19]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["23928"],"URL":"https:\/\/doi.org\/10.1186\/s12889-025-23928-1","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,19]]},"assertion":[{"value":"25 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2833"}}